OrbusNeich Combo stent™

DEVICE2 trials

Sponsors

OrbusNeich

Conditions

Coronary ArteriosclerosisNon ST Segment Elevation Acute Coronary Syndrome

Unknown Phase

HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt

CompletedNCT02073565

OrbusNeichCoronary Arteriosclerosis, Non ST Segment Elevation Acute Coronary Syndrome

Start: 2014-02-28End: 2021-12-31Updated: 2022-05-13

Safety and Efficacy of the Combo Bio-engineered Sirolimus-eluting Stent Versus the Nano Polymer-free Sirolimus-eluting Stent in the Treatment of Patients With de Novo Stenotic Lesions

CompletedNCT02542007

OrbusNeichCoronary Arteriosclerosis

Start: 2015-05-31End: 2021-06-10Updated: 2021-09-09

Related Papers

Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of OrbusNEich's Combo StEnt (Japan-USA HARMONEE) study: primary results of the pivotal registration study of combined endothelial progenitor cell capture and drug-eluting stent in patients with ischaemic coronary disease and non-ST-elevation acute coronary syndrome.

2018-07-0144 citations

Rationale and design of the Japan-USA harmonized assessment by randomized, multicenter study of OrbusNEich's combo StEnt (Japan-USA HARMONEE): Assessment of a novel DES platform for percutaneous coronary revascularization in patients with ischemic coronary disease and non-ST-elevation acute coronary syndrome.

2017-02-122 citations